Stoke Therapeutics, Inc.

STOK·NasdaqGS·Healthcare
Compare
27.45+0.46 (+1.70%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close26.99
Open27.75
Day range26.6027.75
52-week range20.3240.22
Off day high−1.08%
Off 52-week high−31.75%
Volume1.15M
Avg. volume (3M)1.03M
Market cap1.78B
EPS (TTM)-3.81
Forward P/E-7.29
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.38
Shares outstanding64.81M
Short interest16.43% of float
Earnings dateOct 29, 2026
Analyst target46.38
Profit margin0.00%

Against its peers

Compare in full ›
STOK DSGN IRD SRPT MGTX 4591.T
Market cap 1.78B 665.24M 355.25M 2.01B 904.72M 3.39B
P/E (TTM) — — — — 10.8 —
Forward P/E -7.3 -6.6 -6.0 7.8 -6.2 -1.1
Price/book 5.0 3.0 -27.2 1.3 4.1 1.2
Dividend yield — — — — — —
1-year change +18.27% +57.86% +85.38% +7.65% +10.96% −29.21%
Today +1.70% +2.80% +8.65% +2.43% −1.05% −4.76%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Stoke Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Design Therapeutics, Inc.DSGN · Biotechnology 665.24M 10.63 +2.80%
Opus Genetics, Inc.IRD · Biotechnology 355.25M 4.2700 +8.65%
Sarepta Therapeutics, Inc.SRPT · Biotechnology 2.01B 18.99 +2.43%
MeiraGTx Holdings plcMGTX · Biotechnology 904.72M 9.42 −1.05%
Ribomic Inc.4591.T · Biotechnology 3.39B 60.00 −4.76%
Ocugen, Inc.OCGN · Biotechnology 296.55M 0.8745 +17.35%
uniQure N.V.QURE · Biotechnology 1.60B 23.03 −3.52%
Ultragenyx Pharmaceutical Inc.RARE · Biotechnology 1.69B 17.16 +3.19%

Also based in Bedford, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Lantheus Holdings, Inc.LNTH · Bedford, MA 6.60B 101.14 +0.34%
Novanta Inc.NOVT · Bedford, MA 5.49B 145.23 −1.53%
Ocular Therapeutix, Inc.OCUL · Bedford, MA 1.57B 7.14 +4.69%
Anika Therapeutics, Inc.ANIK · Bedford, MA 273.01M 20.40 +4.88%
The TJX Companies, Inc.TJX · Framingham, MA 159.23B 144.76 +5.18%
Vertex Pharmaceuticals IncorporatedVRTX · Boston, MA 139.16B 549.04 +3.44%
Moderna, Inc.MRNA · Cambridge, MAOdds 103.15B 258.38 +13.11%
American Tower CorporationAMT · Boston, MA 90.37B 194.86 +4.04%

The stocks whose daily moves over the past year went most closely with Stoke Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
4D Molecular Therapeutics, Inc.FDMT · Correlation 0.43 678.40M 12.28 +2.76%
Moderna, Inc.MRNA · Correlation 0.40Odds 103.15B 258.38 +13.11%
Kailera Therapeutics, Inc.KLRA · Correlation 0.39 1.66B 12.80 +1.75%
MeiraGTx Holdings plcMGTX · Correlation 0.39 904.72M 9.42 −1.05%
Sarepta Therapeutics, Inc.SRPT · Correlation 0.37 2.01B 18.99 +2.43%
Scholar Rock Holding CorporationSRRK · Correlation 0.37 5.61B 46.09 +4.80%
Design Therapeutics, Inc.DSGN · Correlation 0.35 665.24M 10.63 +2.80%
uniQure N.V.QURE · Correlation 0.35 1.60B 23.03 −3.52%

What visitors to Stoke Therapeutics's page also look at.

Company Mkt cap Price Today
Alector, Inc.ALEC 254.58M 2.2800 +11.22%
Gossamer Bio, Inc.GOSS 60.86M 9.95 +7.22%
Phathom Pharmaceuticals, Inc.PHAT 461.74M 5.68 −1.05%
4D Molecular Therapeutics, Inc.FDMT 678.40M 12.28 +2.76%
Scholar Rock Holding CorporatioSRRK 5.61B 46.09 +4.80%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All STOK news ›
Stoke Therapeutics··2 outletsPositive

Stoke Therapeutics Announces Completion of Successful Meeting with the FDA to Align on Planned U.S. NDA for Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome

– Analysis of the Phase 3 EMPEROR key secondary endpoint of changes in cognition and behavior will be performed using a multicomponent assessment of four Vineland-3 subdomains – – Phase 3 readout anticipated in the third quarter of 2027 to…

STOKPFE
More from 1 other outlet
Seeking Alpha·Positive

Stoke Therapeutics: The Market Misread A Key FDA Win

Explore Stoke Therapeutics (STOK) ahead of the 2027 zorevunersen Dravet readout—cash runway to 2028, FDA endpoint edge, and upside valuation. - Stoke Therapeutics is positioned for a pivotal 2027 readout of zorevunersen, potentially the…

LLYNVOPFESTOK
BioSpace··2 outlets

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - October 16, 2026

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. The…

METADFTXACHV
More from 1 other outlet

From the 4Search news index, newest first.

In the news

22mentions in 30 days
21with it in the headline
Positivesentiment

Mentioned with

U.S. Food and Drug Administration13Stoke Media10Stoke Therapeutics, Inc8Stoke Therapeutics, Inc.7Pfizer6Eli Lilly5Novo Nordisk5Iovance Biotherapeutics4

People in the coverage

Ian F. Smith12Aschettino8Jason Hoitt8Zorevunersen6Alexander5Barry Ticho5

Themes

Healthcare12Massachusetts8Biotechnology7FDA6Health6Reports5SEC Filings5Biotech4

Most coverage from

  1. marketscreener.com8
  2. seekingalpha.com4
  3. defenseworld.net2
  4. investor.stoketherapeutics.com2
  5. themarketsdaily.com2

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 22 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance